News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Lipid Sciences, Inc. (LIPD) Receives Approval To Begin Human Clinical Trial From The Institutional Review Board Of MedStar Research Institute


4/20/2006 12:28:44 PM

Lipid Sciences, Inc. (NASDAQ: LIPD) today announced that the Company had received notification from the Institutional Review Board (IRB) of Medstar Research Institute that approval had been given to begin a human clinical trial of Lipid Sciences' Plasma Delipidation System-2 (PDS-2). With this approval, all conditions set by the FDA earlier this year have now been met for the initiation of the trial.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES